The global femtech market is anticipated to grow at 11.50% CAGR owing to its application in all the crucial domains of women's healthcare such as uterine healthcare, general health, reproductive health, availability of innovative alternatives for educating, and de-stigmatizing women’s health issues, pregnancy, pelvic and nursing care. Moreover, digital health has created opportunities in the femtech market like digital birth control, wearable breast pumps, etc. In addition, the proliferation of mobile phone apps, adoption of healthcare strategies led to the participation of women in clinical studies, and the rising prevalence of chronic and infectious diseases among the female population will lead to an increase in the demand for diagnosis and treatment solutions, resulting in the growth of the femtech market.

The COVID-19 pandemic has seen mental health issues in women’s health and a global increase in pregnancy, both planned and unplanned in addition to stillbirths, rising need for digital solutions has led to the growth of the femtech market.

Request to get a free sample copy at https://www.vynzresearch.com/healthcare/femtech-market/request-sample

Based on application, pregnancy & nursing acre application dominates the market owing to rising demand for innovative products and consumables during pregnancy & nursing. General healthcare and wellness are anticipated to have a high CAGR owing to the rising awareness among women about early detection of disease leading to better diagnostic and screening technologies.

North America dominates the global femtech market owing to the increased women's health education and increased emphasis to promote women’s wellbeing and safety will propel the growth of the femtech market in the region. Asia-Pacific is anticipated to have a high CAGR owing to the increased patient pool having chronic and infectious diseases, and industry players emphasizing delivering reliable, high quality, and user-friendly tools and solutions to enhance women’s lives and geographical expansion in the femtech industry.

Flo, a fertility-tracker app, has USD 50 million Series B funding to provide users with “curated” cycle tracking and forecasts, personalized health insights, and real-time health alerts.

The prominent players in the femtech industry include Alyk, Inc., Aytu BioPharma, Inc., BioWink GmbH, Sustain Natural, Bloomlife, Glow, Inc., NaturalCycles Nordic AB, Ovia Health, Flo Health, Inc., HeraMed Ltd.

Source: VynZ Research